GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
Natural gas mineral firm WhiteHawk reveals sevenfold revenue surge in US IPO filingWhiteHawk, a leading natural gas royalty firm, is taking the stock market plunge with its initial public offering. This comes on the heels ...
US stocks today: Rare Earths Americas kicks off US IPO roadshow with $368 million valuation targetRare Earths Americas kicked off the roadshow for its U.S. initial public offering on Tuesday, aiming for a valuation of up to $368.4 mill...
AMD stock surges past $300 as AI demand and analyst upgrades boost momentumAMD stock is rising fast and crossing key levels as demand for AI chips grows and analysts give positive targets. The company is getting st...
SpaceX lines up 21 banks for mega IPO, code-named project ApexSpaceX is preparing for a massive initial public offering. The rocket company is collaborating with over 20 banks for its upcoming stock ma...
Bitcoin price today drops to $69,000: Why Stifel analysts predict BTC USD could crash further to hit $38,000?Bitcoin price BTC USD prediction: Bitcoin's outlook darkens as analysts foresee a potential drop to $38,000. Historical data shows signific...
Micron stock price: Why MU shares are rising today and what's the new price targetMicron (MU) stock price: Micron Technology shares surged after Stifel raised its price target to $360, citing strong AI cloud demand and im...
Oracle stock soars after revealing massive $30 billion annual cloud deal in filingOracle shares surged to a record high after an SEC filing revealed a cloud deal projected to generate over $30 billion in annual revenue st...
Brace for impact: Stagflation fears could wipe 10% off stocks, says Wall Street’s Doom Prophet Barry BannisterWall Street fears stagflation in the US economy as early as mid-2025. Stifel's Barry Bannister is expecting flat growth accompanied by ongo...
Is Tesla’s stock declining due to Elon Musk’s support for Donald Trump? Here’s what analysts sayAs Tesla navigates an increasingly competitive EV market, all eyes will be on Musk’s next move.
‘Mania’ could drive S&P to 6,000 before plunge, Stifel saysStifel, Nicolaus & Co. predicts a potential 10% rally for the S&P 500 Index this year, reaching 6,000 by 2024. However, Barry Bannister war...
RP-Sanjiv Goenka, Bain Capital, Dorf Ketal in race to buy AquapharmAquapharm is a specialty chemical manufacturer and offers a range of products from phosphonates to pharmaceutical intermediaries. It deals ...
US stock market: Wall Street ends sharply higher as investors eye inflation dataHowever, volume on U.S. exchanges was relatively light, with 9.5 billion shares traded, compared to an average of 11.9 billion shares over ...
Newest meme stocks extend gains with no sign of craze fadingTrading in so-called meme stocks took off this week, with chatter building on WallStreetBets and other social media platforms on the potent...
Buffett's Berkshire takes on short sellers with bet on furniture retailerThe disclosure that Berkshire bought 1.2 million shares sent RH soaring to a fresh record.
- MS deal cuts chances of Yahoo merger
Microsoft's $6 bn deal to buy aQuantive Inc reduces the chances of the software giant buying with Yahoo.